Humira, a 20 billion dollar drug, loses its patent in 19 mon...

Humira, a 20 billion dollar drug, loses its patent in 19 months. The FDA has already granted 5 approvals for generic versions of the drug. Humira can only be given by infusion. $Biora Therapeutics (PROG.US)$ Progenity’s pill technology will acquired by a drug company, which one will remain to be seen. There is a lot of money at stake, and someone will want to own the patent. Humira’s generic version are set to hit the market starting 7/1/23 with the last generic approved going into effect 9/30/23. This is a long term hold for me.